封面
市場調查報告書
商品編碼
1862160

橫向流動化驗檢測:全球市場佔有率和排名、總收入和需求預測(2025-2031 年)

Lateral Flow Assay Test - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

出版日期: | 出版商: QYResearch | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球橫向流動化驗偵測市場預計在 2024 年達到 58.92 億美元,預計到 2031 年將達到 85.66 億美元,2025 年至 2031 年的複合年成長率為 6.2%。

橫向流動化驗是一種簡單的診斷設備,用於確認人類和動物體內是否有感興趣的分析物,例如病原體和生物標記物,或自來水、食物和飼料中的污染物。

全球橫向流動化驗檢測市場的主要企業包括賽默飛世爾科技(Thermo Fisher)和貝克頓·迪金森公司(Becton Dickinson)。這兩家公司合計佔約25%的總合。北美是最大的市場,市佔率超過35%,其次是歐洲和亞太地區,市佔率均約為55%。依產品類型分類,夾心法檢測是最大的區隔市場,約佔市場佔有率的65%。依應用領域分類,醫療領域是最大的應用領域,其次是環境檢測和食品安全。

側向流動檢測產業:技術主導的市場創新與公司轉型

在技​​術創新的驅動下,側向流動檢測產業正在重塑醫療診斷、食品安全和環境監測等領域的檢測模式。其核心優勢在於操作簡單、快速定性分析,應用範圍從病原體檢測擴展到污染物篩檢,應用場景也日益多元化。目前,該產業的技術演進正從傳統檢測套組轉向數位化、智慧型設備。數位化和行動讀板的廣泛應用顯著提高了檢測效率和數據可追溯性,而最佳化檢測套組的靈敏度和特異性已成為競爭優勢。這項技術演進不僅滿足了醫療領域對即時就地檢驗(POC​​T)的需求,也有助於食品加工企業提升原料污染快速篩檢能力,進而形成「技術-應用-需求」的良性循環。

市場動態與成長邏輯:需求擴張與政策的綜效

不斷成長的市場需求是推動產業成長的核心動力。在醫療健康領域,從三級醫療機構到基層醫療機構,對攜帶式檢測設備的需求激增,帶動試劑和設備市場的同步擴張。在食品業,在「從農場到餐桌」的全面監管體系下,企業對快速檢測技術的投資穩定成長。在政策層面,政府透過「支持新型產業生產力發展的計量行動計畫(2025-2030年)」等文件,將計量技術納入策略支援領域,鼓勵企業克服技術瓶頸。同時,資本市場對該產業的興趣也顯著提升。根據主要證券機構的研究報告顯示,在有利的政策和流動性支持下,到2025年,側向流動檢測行業的業績和估值預計將呈指數級成長。尤其具有國際競爭力的企業,正透過跨國併購和海外擴張不斷擴大全球市場佔有率。商業展望:技術壁壘、深化發展情境與生態系統建設

主要企業正透過三大途徑強化自身競爭優勢。首先,它們建構技術壁壘。例如,丹納赫和Bio-Rad透過持續的研發投入,在試劑靈敏度和儀器整合方面建構了專利支援的防禦體系。其次,基於場景的解決方案正從獨立產品轉向「檢測+資訊服務」。例如,它們為醫院提供客製化的檢測方案,並為食品企業建立全流程可追溯性系統。第三,全球生態系統協作正在促進合作。主要企業正透過併購和設立海外分公司拓展國際市場。例如,中金公司正利用其國際影響力,透過在香港進行股權資金籌措快速擴張;而中國銀河證券則透過其東南亞子公司擴大其在證券經紀市場的佔有率。此外,區塊鏈和物聯網等技術的融合正在建立封閉回路型生態系統。例如,將檢測數據與區塊鏈結合,可以確保食品供應鏈的透明度和可追溯性。

展望:創新重塑產業格局

側向流動檢測產業的未來屬於那些能夠將技術突破轉化為增值應用場景的企業。人工智慧、巨量資料與環境等關鍵領域。同時,透過全球擴張和生態系統合作,企業可以從「檢測工具提供者」轉型為「產業解決方案領導者」。在此過程中,那些展現出持續創新能力並精準掌握客戶需求的企業,將在技術主導的產業轉型中佔主導。

本報告旨在依地區/國家、類型和應用對全球橫向流動化驗檢測市場進行全面分析,重點關注總收入、市場佔有率和主要企業的排名。

本報告以銷售收入為指標,對橫向流動化驗市場規模、估算和預測進行了呈現,以 2024 年為基準年,並包含了 2020 年至 2031 年的歷史數據和預測數據。透過定量和定性分析,我們幫助讀者制定業務/成長策略,評估競爭格局,分析自身在當前市場中的地位,並就橫向流動化驗做出明智的商業決策。

市場區隔

公司

  • Thermo Fisher
  • Becton Dickinson
  • Abbott
  • Hologic, Inc.
  • PerkinElmer
  • Quidel Corporation
  • Biomerieux
  • Cytiva(Danaher)
  • Qiagen
  • Siemens
  • BUHLMANN
  • IMMY

依類型分類的區隔市場

  • 夾心法
  • 競爭性檢測

應用領域

  • 製藥
  • 環境測試
  • 食品安全

依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Lateral Flow Assay Test was estimated to be worth US$ 5892 million in 2024 and is forecast to a readjusted size of US$ 8566 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.

Lateral Flow Assay is a simple to use diagnostic device used to confirm the presence or absence of a target analyte, such as pathogens or biomarkers in humans or animals, or contaminants in water supplies, foodstuffs, or animal feeds.

Global Lateral Flow Assay Test key players include Thermo Fisher, Becton Dickinson, etc. Global top two manufacturers hold a share nearly 25%. North America is the largest market, with a share over 35%, followed by Europe, Asia-Pacific, both have a share about 55 percent. In terms of product, Sandwich Assays is the largest segment, with a share about 65%. And in terms of application, the largest application is Medicine, followed by Environment Testing, Food Safety, etc.

Lateral Flow Test Industry: Technology-Driven Market Innovation and Enterprise Transformation

The lateral flow test industry, driven by technological iteration, is reshaping the testing paradigm in fields such as medical diagnostics, food safety, and environmental monitoring. Its essence lies in enabling rapid qualitative analysis through simple operation, extending its reach from pathogen detection to contaminant screening, and its application scenarios continue to diversify. Currently, the industry's technological path is shifting from traditional test kits to digital and intelligent devices. The widespread adoption of digital/mobile readers has significantly improved testing efficiency and data traceability, while optimizing test kit sensitivity and specificity has become a key differentiator in competitive competition. This technological evolution not only meets the medical field's demand for immediate point-of-care testing (POCT) but also drives food processing companies to upgrade their capabilities for rapid screening of raw material contamination, creating a virtuous cycle of "technology-application-demand."

Market Dynamics and Growth Logic: Increasing Demand and Policy Resonance

Increasing market demand has become the core driver of industry growth. In the medical sector, from tertiary hospitals to primary care clinics, demand for portable testing equipment has surged, driving the simultaneous expansion of the reagent and instrument markets. In the food industry, under comprehensive "farm-to-table" oversight, companies' investment in rapid testing technology has steadily increased. On the policy front, the government, through documents such as the "Action Plan for Metrology to Support the Development of New Industrial Productivity (2025-2030)," has incorporated metrology technology into strategic support areas, encouraging companies to overcome key technological bottlenecks. Meanwhile, capital markets are significantly increasing their interest in the industry. Research reports from leading brokerages indicate that the lateral flow testing sector is expected to see a boost in both performance and valuation by 2025, driven by favorable policies and liquidity. Internationally competitive companies, in particular, are seizing global market share through cross-border mergers and acquisitions and overseas expansion. Business Outlook: Technological Barriers, Deepening Scenario Development, and Ecosystem Building

Leading companies are consolidating their competitive advantages through three main approaches: First, building technological barriers. For example, Danaher and Bio-Rad have built patent moats in reagent sensitivity and device integration through continuous R&D investment. Second, scenario-based solutions are transitioning from single products to "testing + data services." For example, they offer customized testing packages to hospitals or build full-process traceability systems for food companies. Third, global ecosystem collaboration is fostering collaboration. Leading companies are expanding into international markets through mergers and acquisitions or establishing overseas branches. For example, CICC, leveraging its international presence, has rapidly expanded in Hong Kong equity financing, while China Galaxy Securities is increasing its brokerage market share through its Southeast Asian subsidiary. Furthermore, the integration of technologies like blockchain and the Internet of Things is fostering a closed-loop ecosystem of "testing-data-decision-making." For example, combining test data with blockchain ensures transparency and traceability in the food supply chain.

Future Outlook: Industry Restructuring Driven by Innovation

The future of the lateral flow testing industry belongs to those companies that can transform technological breakthroughs into valuable scenarios. With the deep integration of artificial intelligence, big data, and testing technologies, intelligent testing platforms will become standard, and policy support and capital injection will accelerate industry restructuring. Companies need to leverage "technology + scenarios + ecosystem" as their strategic fulcrum, delving deeply into essential sectors like healthcare, food, and the environment. Simultaneously, through global expansion and ecosystem collaboration, they can upgrade from "testing tool providers" to "industry solution leaders." In this process, those who consistently innovate and accurately understand customer needs will seize the initiative in this technology-driven industrial transformation.

This report aims to provide a comprehensive presentation of the global market for Lateral Flow Assay Test, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Lateral Flow Assay Test by region & country, by Type, and by Application.

The Lateral Flow Assay Test market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lateral Flow Assay Test.

Market Segmentation

By Company

  • Thermo Fisher
  • Becton Dickinson
  • Abbott
  • Hologic, Inc.
  • PerkinElmer
  • Quidel Corporation
  • Biomerieux
  • Cytiva (Danaher)
  • Qiagen
  • Siemens
  • BUHLMANN
  • IMMY

Segment by Type

  • Sandwich Assays
  • Competitive Assays

Segment by Application

  • Medicine
  • Environment Testing
  • Food Safety

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Lateral Flow Assay Test company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Lateral Flow Assay Test in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Lateral Flow Assay Test in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Lateral Flow Assay Test Product Introduction
  • 1.2 Global Lateral Flow Assay Test Market Size Forecast (2020-2031)
  • 1.3 Lateral Flow Assay Test Market Trends & Drivers
    • 1.3.1 Lateral Flow Assay Test Industry Trends
    • 1.3.2 Lateral Flow Assay Test Market Drivers & Opportunity
    • 1.3.3 Lateral Flow Assay Test Market Challenges
    • 1.3.4 Lateral Flow Assay Test Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Lateral Flow Assay Test Players Revenue Ranking (2024)
  • 2.2 Global Lateral Flow Assay Test Revenue by Company (2020-2025)
  • 2.3 Key Companies Lateral Flow Assay Test Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Lateral Flow Assay Test Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Lateral Flow Assay Test
  • 2.6 Lateral Flow Assay Test Market Competitive Analysis
    • 2.6.1 Lateral Flow Assay Test Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Lateral Flow Assay Test Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lateral Flow Assay Test as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Sandwich Assays
    • 3.1.2 Competitive Assays
  • 3.2 Global Lateral Flow Assay Test Sales Value by Type
    • 3.2.1 Global Lateral Flow Assay Test Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Lateral Flow Assay Test Sales Value, by Type (2020-2031)
    • 3.2.3 Global Lateral Flow Assay Test Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Medicine
    • 4.1.2 Environment Testing
    • 4.1.3 Food Safety
  • 4.2 Global Lateral Flow Assay Test Sales Value by Application
    • 4.2.1 Global Lateral Flow Assay Test Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Lateral Flow Assay Test Sales Value, by Application (2020-2031)
    • 4.2.3 Global Lateral Flow Assay Test Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Lateral Flow Assay Test Sales Value by Region
    • 5.1.1 Global Lateral Flow Assay Test Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Lateral Flow Assay Test Sales Value by Region (2020-2025)
    • 5.1.3 Global Lateral Flow Assay Test Sales Value by Region (2026-2031)
    • 5.1.4 Global Lateral Flow Assay Test Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Lateral Flow Assay Test Sales Value, 2020-2031
    • 5.2.2 North America Lateral Flow Assay Test Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Lateral Flow Assay Test Sales Value, 2020-2031
    • 5.3.2 Europe Lateral Flow Assay Test Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Lateral Flow Assay Test Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Lateral Flow Assay Test Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Lateral Flow Assay Test Sales Value, 2020-2031
    • 5.5.2 South America Lateral Flow Assay Test Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Lateral Flow Assay Test Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Lateral Flow Assay Test Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Lateral Flow Assay Test Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Lateral Flow Assay Test Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Lateral Flow Assay Test Sales Value, 2020-2031
    • 6.3.2 United States Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Lateral Flow Assay Test Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Lateral Flow Assay Test Sales Value, 2020-2031
    • 6.4.2 Europe Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Lateral Flow Assay Test Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Lateral Flow Assay Test Sales Value, 2020-2031
    • 6.5.2 China Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Lateral Flow Assay Test Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Lateral Flow Assay Test Sales Value, 2020-2031
    • 6.6.2 Japan Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Lateral Flow Assay Test Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Lateral Flow Assay Test Sales Value, 2020-2031
    • 6.7.2 South Korea Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Lateral Flow Assay Test Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Lateral Flow Assay Test Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Lateral Flow Assay Test Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Lateral Flow Assay Test Sales Value, 2020-2031
    • 6.9.2 India Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Lateral Flow Assay Test Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Thermo Fisher
    • 7.1.1 Thermo Fisher Profile
    • 7.1.2 Thermo Fisher Main Business
    • 7.1.3 Thermo Fisher Lateral Flow Assay Test Products, Services and Solutions
    • 7.1.4 Thermo Fisher Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Thermo Fisher Recent Developments
  • 7.2 Becton Dickinson
    • 7.2.1 Becton Dickinson Profile
    • 7.2.2 Becton Dickinson Main Business
    • 7.2.3 Becton Dickinson Lateral Flow Assay Test Products, Services and Solutions
    • 7.2.4 Becton Dickinson Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Becton Dickinson Recent Developments
  • 7.3 Abbott
    • 7.3.1 Abbott Profile
    • 7.3.2 Abbott Main Business
    • 7.3.3 Abbott Lateral Flow Assay Test Products, Services and Solutions
    • 7.3.4 Abbott Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
    • 7.3.5 Abbott Recent Developments
  • 7.4 Hologic, Inc.
    • 7.4.1 Hologic, Inc. Profile
    • 7.4.2 Hologic, Inc. Main Business
    • 7.4.3 Hologic, Inc. Lateral Flow Assay Test Products, Services and Solutions
    • 7.4.4 Hologic, Inc. Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Hologic, Inc. Recent Developments
  • 7.5 PerkinElmer
    • 7.5.1 PerkinElmer Profile
    • 7.5.2 PerkinElmer Main Business
    • 7.5.3 PerkinElmer Lateral Flow Assay Test Products, Services and Solutions
    • 7.5.4 PerkinElmer Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
    • 7.5.5 PerkinElmer Recent Developments
  • 7.6 Quidel Corporation
    • 7.6.1 Quidel Corporation Profile
    • 7.6.2 Quidel Corporation Main Business
    • 7.6.3 Quidel Corporation Lateral Flow Assay Test Products, Services and Solutions
    • 7.6.4 Quidel Corporation Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Quidel Corporation Recent Developments
  • 7.7 Biomerieux
    • 7.7.1 Biomerieux Profile
    • 7.7.2 Biomerieux Main Business
    • 7.7.3 Biomerieux Lateral Flow Assay Test Products, Services and Solutions
    • 7.7.4 Biomerieux Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Biomerieux Recent Developments
  • 7.8 Cytiva (Danaher)
    • 7.8.1 Cytiva (Danaher) Profile
    • 7.8.2 Cytiva (Danaher) Main Business
    • 7.8.3 Cytiva (Danaher) Lateral Flow Assay Test Products, Services and Solutions
    • 7.8.4 Cytiva (Danaher) Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Cytiva (Danaher) Recent Developments
  • 7.9 Qiagen
    • 7.9.1 Qiagen Profile
    • 7.9.2 Qiagen Main Business
    • 7.9.3 Qiagen Lateral Flow Assay Test Products, Services and Solutions
    • 7.9.4 Qiagen Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Qiagen Recent Developments
  • 7.10 Siemens
    • 7.10.1 Siemens Profile
    • 7.10.2 Siemens Main Business
    • 7.10.3 Siemens Lateral Flow Assay Test Products, Services and Solutions
    • 7.10.4 Siemens Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Siemens Recent Developments
  • 7.11 BUHLMANN
    • 7.11.1 BUHLMANN Profile
    • 7.11.2 BUHLMANN Main Business
    • 7.11.3 BUHLMANN Lateral Flow Assay Test Products, Services and Solutions
    • 7.11.4 BUHLMANN Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
    • 7.11.5 BUHLMANN Recent Developments
  • 7.12 IMMY
    • 7.12.1 IMMY Profile
    • 7.12.2 IMMY Main Business
    • 7.12.3 IMMY Lateral Flow Assay Test Products, Services and Solutions
    • 7.12.4 IMMY Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
    • 7.12.5 IMMY Recent Developments

8 Industry Chain Analysis

  • 8.1 Lateral Flow Assay Test Industrial Chain
  • 8.2 Lateral Flow Assay Test Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Lateral Flow Assay Test Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Lateral Flow Assay Test Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Lateral Flow Assay Test Market Trends
  • Table 2. Lateral Flow Assay Test Market Drivers & Opportunity
  • Table 3. Lateral Flow Assay Test Market Challenges
  • Table 4. Lateral Flow Assay Test Market Restraints
  • Table 5. Global Lateral Flow Assay Test Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Lateral Flow Assay Test Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Lateral Flow Assay Test Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Lateral Flow Assay Test Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Lateral Flow Assay Test
  • Table 10. Global Lateral Flow Assay Test Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lateral Flow Assay Test as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Lateral Flow Assay Test Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Lateral Flow Assay Test Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Lateral Flow Assay Test Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Lateral Flow Assay Test Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Lateral Flow Assay Test Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Lateral Flow Assay Test Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Lateral Flow Assay Test Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Lateral Flow Assay Test Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Lateral Flow Assay Test Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Lateral Flow Assay Test Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Lateral Flow Assay Test Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Lateral Flow Assay Test Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Lateral Flow Assay Test Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Lateral Flow Assay Test Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Lateral Flow Assay Test Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Lateral Flow Assay Test Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Lateral Flow Assay Test Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Lateral Flow Assay Test Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Thermo Fisher Basic Information List
  • Table 32. Thermo Fisher Description and Business Overview
  • Table 33. Thermo Fisher Lateral Flow Assay Test Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Lateral Flow Assay Test Business of Thermo Fisher (2020-2025)
  • Table 35. Thermo Fisher Recent Developments
  • Table 36. Becton Dickinson Basic Information List
  • Table 37. Becton Dickinson Description and Business Overview
  • Table 38. Becton Dickinson Lateral Flow Assay Test Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Lateral Flow Assay Test Business of Becton Dickinson (2020-2025)
  • Table 40. Becton Dickinson Recent Developments
  • Table 41. Abbott Basic Information List
  • Table 42. Abbott Description and Business Overview
  • Table 43. Abbott Lateral Flow Assay Test Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Lateral Flow Assay Test Business of Abbott (2020-2025)
  • Table 45. Abbott Recent Developments
  • Table 46. Hologic, Inc. Basic Information List
  • Table 47. Hologic, Inc. Description and Business Overview
  • Table 48. Hologic, Inc. Lateral Flow Assay Test Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Lateral Flow Assay Test Business of Hologic, Inc. (2020-2025)
  • Table 50. Hologic, Inc. Recent Developments
  • Table 51. PerkinElmer Basic Information List
  • Table 52. PerkinElmer Description and Business Overview
  • Table 53. PerkinElmer Lateral Flow Assay Test Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Lateral Flow Assay Test Business of PerkinElmer (2020-2025)
  • Table 55. PerkinElmer Recent Developments
  • Table 56. Quidel Corporation Basic Information List
  • Table 57. Quidel Corporation Description and Business Overview
  • Table 58. Quidel Corporation Lateral Flow Assay Test Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Lateral Flow Assay Test Business of Quidel Corporation (2020-2025)
  • Table 60. Quidel Corporation Recent Developments
  • Table 61. Biomerieux Basic Information List
  • Table 62. Biomerieux Description and Business Overview
  • Table 63. Biomerieux Lateral Flow Assay Test Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Lateral Flow Assay Test Business of Biomerieux (2020-2025)
  • Table 65. Biomerieux Recent Developments
  • Table 66. Cytiva (Danaher) Basic Information List
  • Table 67. Cytiva (Danaher) Description and Business Overview
  • Table 68. Cytiva (Danaher) Lateral Flow Assay Test Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Lateral Flow Assay Test Business of Cytiva (Danaher) (2020-2025)
  • Table 70. Cytiva (Danaher) Recent Developments
  • Table 71. Qiagen Basic Information List
  • Table 72. Qiagen Description and Business Overview
  • Table 73. Qiagen Lateral Flow Assay Test Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Lateral Flow Assay Test Business of Qiagen (2020-2025)
  • Table 75. Qiagen Recent Developments
  • Table 76. Siemens Basic Information List
  • Table 77. Siemens Description and Business Overview
  • Table 78. Siemens Lateral Flow Assay Test Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Lateral Flow Assay Test Business of Siemens (2020-2025)
  • Table 80. Siemens Recent Developments
  • Table 81. BUHLMANN Basic Information List
  • Table 82. BUHLMANN Description and Business Overview
  • Table 83. BUHLMANN Lateral Flow Assay Test Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Lateral Flow Assay Test Business of BUHLMANN (2020-2025)
  • Table 85. BUHLMANN Recent Developments
  • Table 86. IMMY Basic Information List
  • Table 87. IMMY Description and Business Overview
  • Table 88. IMMY Lateral Flow Assay Test Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in Lateral Flow Assay Test Business of IMMY (2020-2025)
  • Table 90. IMMY Recent Developments
  • Table 91. Key Raw Materials Lists
  • Table 92. Raw Materials Key Suppliers Lists
  • Table 93. Lateral Flow Assay Test Downstream Customers
  • Table 94. Lateral Flow Assay Test Distributors List
  • Table 95. Research Programs/Design for This Report
  • Table 96. Key Data Information from Secondary Sources
  • Table 97. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Lateral Flow Assay Test Product Picture
  • Figure 2. Global Lateral Flow Assay Test Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Lateral Flow Assay Test Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Lateral Flow Assay Test Report Years Considered
  • Figure 5. Global Lateral Flow Assay Test Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Lateral Flow Assay Test Revenue in 2024
  • Figure 7. Lateral Flow Assay Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Sandwich Assays Picture
  • Figure 9. Competitive Assays Picture
  • Figure 10. Global Lateral Flow Assay Test Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 11. Global Lateral Flow Assay Test Sales Value Market Share by Type, 2024 & 2031
  • Figure 12. Product Picture of Medicine
  • Figure 13. Product Picture of Environment Testing
  • Figure 14. Product Picture of Food Safety
  • Figure 15. Global Lateral Flow Assay Test Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 16. Global Lateral Flow Assay Test Sales Value Market Share by Application, 2024 & 2031
  • Figure 17. North America Lateral Flow Assay Test Sales Value (2020-2031) & (US$ Million)
  • Figure 18. North America Lateral Flow Assay Test Sales Value by Country (%), 2024 VS 2031
  • Figure 19. Europe Lateral Flow Assay Test Sales Value, (2020-2031) & (US$ Million)
  • Figure 20. Europe Lateral Flow Assay Test Sales Value by Country (%), 2024 VS 2031
  • Figure 21. Asia Pacific Lateral Flow Assay Test Sales Value, (2020-2031) & (US$ Million)
  • Figure 22. Asia Pacific Lateral Flow Assay Test Sales Value by Region (%), 2024 VS 2031
  • Figure 23. South America Lateral Flow Assay Test Sales Value, (2020-2031) & (US$ Million)
  • Figure 24. South America Lateral Flow Assay Test Sales Value by Country (%), 2024 VS 2031
  • Figure 25. Middle East & Africa Lateral Flow Assay Test Sales Value, (2020-2031) & (US$ Million)
  • Figure 26. Middle East & Africa Lateral Flow Assay Test Sales Value by Country (%), 2024 VS 2031
  • Figure 27. Key Countries/Regions Lateral Flow Assay Test Sales Value (%), (2020-2031)
  • Figure 28. United States Lateral Flow Assay Test Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. United States Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
  • Figure 30. United States Lateral Flow Assay Test Sales Value by Application (%), 2024 VS 2031
  • Figure 31. Europe Lateral Flow Assay Test Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Europe Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
  • Figure 33. Europe Lateral Flow Assay Test Sales Value by Application (%), 2024 VS 2031
  • Figure 34. China Lateral Flow Assay Test Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. China Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
  • Figure 36. China Lateral Flow Assay Test Sales Value by Application (%), 2024 VS 2031
  • Figure 37. Japan Lateral Flow Assay Test Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. Japan Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
  • Figure 39. Japan Lateral Flow Assay Test Sales Value by Application (%), 2024 VS 2031
  • Figure 40. South Korea Lateral Flow Assay Test Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. South Korea Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
  • Figure 42. South Korea Lateral Flow Assay Test Sales Value by Application (%), 2024 VS 2031
  • Figure 43. Southeast Asia Lateral Flow Assay Test Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. Southeast Asia Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
  • Figure 45. Southeast Asia Lateral Flow Assay Test Sales Value by Application (%), 2024 VS 2031
  • Figure 46. India Lateral Flow Assay Test Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. India Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
  • Figure 48. India Lateral Flow Assay Test Sales Value by Application (%), 2024 VS 2031
  • Figure 49. Lateral Flow Assay Test Industrial Chain
  • Figure 50. Lateral Flow Assay Test Manufacturing Cost Structure
  • Figure 51. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 52. Bottom-up and Top-down Approaches for This Report
  • Figure 53. Data Triangulation
  • Figure 54. Key Executives Interviewed